Literature DB >> 24928947

Retraction: molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor i receptor inhibition.

.   

Abstract

Entities:  

Year:  2014        PMID: 24928947      PMCID: PMC4394839          DOI: 10.1158/1078-0432.CCR-14-1118

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  3 in total

1.  Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition.

Authors:  Antonio Gualberto; Marisa Dolled-Filhart; Mark Gustavson; Jason Christiansen; Yu-Fen Wang; Mary L Hixon; Jennifer Reynolds; Sandra McDonald; Agnes Ang; David L Rimm; Corey J Langer; Johnetta Blakely; Linda Garland; Luis G Paz-Ares; Daniel D Karp; Adrian V Lee
Journal:  Clin Cancer Res       Date:  2010-07-29       Impact factor: 12.531

2.  Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

Authors:  Daniel D Karp; Luis G Paz-Ares; Silvia Novello; Paul Haluska; Linda Garland; Felipe Cardenal; L Johnetta Blakely; Peter D Eisenberg; Corey J Langer; George Blumenschein; Faye M Johnson; Stephanie Green; Antonio Gualberto
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

3.  Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.

Authors:  A Gualberto; M L Hixon; D D Karp; D Li; S Green; M Dolled-Filhart; L G Paz-Ares; S Novello; J Blakely; C J Langer; M N Pollak
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

  3 in total
  1 in total

Review 1.  Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases.

Authors:  Zheng Wang; Wenting Li; Qiongya Guo; Yuming Wang; Lijun Ma; Xiaoju Zhang
Journal:  Biomed Res Int       Date:  2018-06-19       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.